Aurora: Finding needles in NCI's haystack

In the vast realm of gene sequencing and analysis, tools designed for use in one area can have unexpected application to another. Aurora Biosciences Corp. last week provided a technology designed as part of its drug screening platform to help complete the National Cancer Institute's effort to index genes involved in tumor development.

The NCI's Cancer Genome Anatomy Project (CGAP) monitors and profiles gene expression in tumor cell lines and makes the information public to see if correlations can be found between the data and gene expression in actual human tumors...